Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Illumina Inc. Stock

Price
 
€289.85
-6.5
-1.810%
Target price
€319.57
24.01.20 / Tradegate WKN: 927079 / Symbol: ILMN / Name: Illumina / Stock / Ausrüstung & Versorgung
Latest predictions
€315.70
13.07.19
buy
€315.70
01.02.19
buy
€323.44
07.01.19
buy
€460.47
18.07.18
buy
€451.00
27.11.17
buy
€234.52
27.11.17
buy
Your prediction

Illumina Inc. Stock

We can see a decrease in the price for Illumina Inc.. Compared to yesterday it has lost -€6.500 (-1.810%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Illumina Inc..
With a target price of €319.00 there is a slightly positive potential of 10.057% for Illumina Inc. compared to the current price of €289.85.
Register To Post

Other discussions about Illumina Inc. Stock

New thread

News

Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020


Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2019 following the close of market on Wednesday, January 29, 2020.



On the same day, at

Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics: https://mms.businesswire.com/media/20200113005753/en/767096/5/nextseq-2000_FINAL_FINAL_for_BusinessWire.jpg
Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics


Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership

Illumina and Roche Partner to Broaden Patient Access to Genomic Testing


Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year

Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom


Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000)

Illumina and Pacific Biosciences Announce Termination of Merger Agreement


Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on

Illumina to Webcast Upcoming Investor Conference Presentation


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invite investors to participate via webcast.



J.P. Morgan Healthcare

Illumina to Webcast Upcoming Investor Conference Presentations


Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.



Evercore ISI HealthCONx